Thrivent Small Cap Fund Q3 2026 Performance

Thrivent Small Cap Fund matches Russell 2000 growth with AI-driven DNA demand.

4 cards · 50s · tap to begin

From · · 50s

Thrivent Small Cap Fund Q3 2026 Performance

Thrivent Small Cap Fund matches Russell 2000 growth with AI-driven DNA demand.

In brief

Thrivent Small Cap Fund matches Russell 2000 growth with AI-driven DNA demand. Thrivent Small Cap Fund grew in line with Russell 2000 in Q3 2026 as AI drug development and cloud migrations boosted revenue. Originally reported by Seekingalpha.

Q3 2026 Performance

Flay Lay Business Finance and Investing Concept Layout

Thrivent Small Cap Fund performed roughly in-line with Russell 2000 Index over last quarter.

AI Drug Development Growth

Easing academic funding headwinds and growing demand for large-scale DNA inputs in AI-driven drug development support stronger revenue expectations.

Cloud Migrations Boost

We expect continued double-digit revenue growth supported near-term by cloud migrations and over time by demand to secure non-human identities.

Portfolio Adjustments

The investment thesis around improving nuclear power orders, new JV services wins, and accelerating shipbuilding growth has largely played out.

The big picture

Thrivent Small Cap Fund grew in line with Russell 2000 in Q3 2026 as AI drug development and cloud migrations boosted revenue.

Read the original on Seekingalpha

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on thrivent small cap stock fund and related topics.